Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate
- 26 June 2008
- journal article
- Published by Elsevier BV in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 70 (3), 726-734
- https://doi.org/10.1016/j.ejpb.2008.06.016
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cisplatin Nephrotoxicity: A ReviewThe American Journal of the Medical Sciences, 2007
- Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cellsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Anticancer Efficacies of Cisplatin-Releasing pH-Responsive NanoparticlesBiomacromolecules, 2006
- Surgical quality in trials of adjuvant cancer therapyJournal of Surgical Oncology, 2002
- PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood propertiesJournal of Controlled Release, 2002
- Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the coreJournal of Controlled Release, 2001
- A Systematic Overview of Chemotherapy Effects in Ovarian CancerActa Oncologica, 2001
- Intra-tumoral injection of doxorubicin (adriamycin) encapsulated in liposome inhibits tumor growth, prolongs survival time and is not associated with local or systemic side effectsInternational Journal of Cancer, 2000
- Introduction of cisplatin into polymeric micelleJournal of Controlled Release, 1996
- Intratumoral ChemotherapyNeurosurgery, 1995